Micron Is Down About 22% From Its High. The AI Memory Story Is Just Getting Started.
Revenue just grew 346% in a single quarter. The selloff may be the opportunity.
Revenue just grew 346% in a single quarter. The selloff may be the opportunity.
CEG completed a $26.6 billion Calpine acquisition and signed long-term nuclear deals with hyperscalers. The valuation is the most interesting it has been in years.
Every drug plant being built in America needs one thing nobody is talking about.
The OCC approval is the headline. The GENIUS Act deadline eight days away is the trade.
The freight cycle is turning, and ODFL is the stock analysts keep reaching for first.
A $21.835B acquisition, a 55-gigawatt fleet, and Q2 earnings arriving in 28 days.
Nvidia’s next earnings are August 26. That’s when the math gets tested.
The largest U.S. manufacturing commitment in Apple history just confirmed Broadcom’s revenue floor through 2031.
Two biopharma giants sitting at opposite ends of the market’s attention span.
Same earnings window, same sector, very different bets.